Anesthesia Intraoral Module (AIM)
The minimally invasive but often painful NORA procedures require deeper sedation with a potential for respiratory depression. It is time to move past the limitations of Face masks & Nasal cannulas.
AIM delivers oxygen and captures exhaled carbon dioxide for capnography in patients undergoing clinical procedures and require monitoring, per the safety guidelines of the American Society of Anesthesiologists (ASA).
Disclaimer: AIM is currently undergoing development and has not been approved by the FDA for patient use.
How is AIM used?
AIM is placed between the teeth of the upper and lower jaw. Oxygen and capnography ports on AIM are connected to the oxygen supply outlet and the capnography monitor.
96% and Higher FiO2 Delivery
AIM’s innovative oxygen delivery closer to the tracheal inlet allows FiO2 of 96% and higher. The efficient system uses significantly less oxygen, providing additional value in situations where oxygen conservation is essential (EMTs with portable oxygen tanks).
AIM was recently tested by a third-party lab in California to collect data for FDA 510(k) submission. The oxygen sensor at the simulated patient’s trachea captured 96% FiO2.
Improved Capnography
Face masks promote CO2 rebreathing or CO2 dilution with O2 flowing under the mask. The artifactual EtCO2 waveform may not accurately reflect a sedated patient’s respiratory status.
AIM’s capnography port captures free-flowing CO2 closer to the trachea for an accurate EtCO2 waveform. An early alert and increased reaction time in a hypoventilating patient can avoid a catastrophic situation in remote hospital locations.
Single-Step Oral Airway Placement
Oral airway placement for upper airway obstruction is a time-consuming, multi-step process (remove face mask, pry the jaw open of a sedated, often uncooperative patient, place oral airway, replace face mask).
With AIM in place, oral airway insertion is a single step, minimizing procedural interruptions and delays.
Seamless Conversion to General Anesthesia
Emergent conversion to general anesthesia occurs secondary to excessive patient movement, extreme discomfort, or respiratory failure.
With an open oral cavity and O2 flowing into the oro-pharynx, AIM replaces the rushed and injury-prone maneuvers with a single-step conversion to general anesthesia.
Eliminates Bite-blocks
EGD and TEE bite-blocks and awake fiber-optic intubation (pink) airways are not needed, saving resources and contaminated medical waste disposal.
May Lower the Risk of Airway Fires
Nasal cannulas and face masks accumulate oxygen around a patient’s face (oxygen is heavier than air), risking airway fires, patient injuries, and malpractice lawsuits.
AIM’s oxygen delivery into the oro-pharynx may help reduce the risk of airway fires.
Small Size, Big Impact
Despite its small size compared to a face mask, AIM’s high oxygen delivery, accurate capnography, seamless airway resuscitation, and patient comfort could make it a suitable device for a wide range of NORA procedures.
Lower Environmental Impact
AIM consumes fewer manufacturing resources due to its compact size.
Additionally, by eliminating the need for EGD and TEE bite-blocks and awake fiberoptic intubation (pink) airways, AIM further lowers disposable consumption.
Manufactured in the USA
With a focus on manufacturing the highest quality medical device, everything from collaborating on the design, device molds, sourcing raw materials, manufacturing, parts assembly, and packaging is done here in the US. No overseas containers, and no supply chain issues.
